Neurones - Public Comps and Valuation Multiples

Neurones Overview

About Neurones

Neurones SA is a France-based technology sector company. Its core business involves the provision of Information Technology (IT) services catering to the needs of hardware, software, and consulting. Its operations are thereby divided into three segments: Infrastructure Services, Application Services, and Consulting. The Infrastructure segment is the strongest revenue driver through the provision of such services as IT operations, IT service management, systems and network, server, application, and workstation outsourcing. Its second profitable business is carried out through the Application segment, which entails SAP, Web and decision support, social media, data analysis.

Founded

1984

HQ

Employees

7.1K+

Website

neurones.net

Sectors

IT Consulting
Service Providers

Financials

LTM Revenue $983M

LTM EBITDA $103M

EV

$803M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Neurones Financials

As of August 2025, Neurones reported last 12-month revenue of $983M and EBITDA of $103M.

In the same period, Neurones achieved $58.2M in LTM net income.

See Neurones valuation multiples based on analyst estimates

Neurones P&L

In the most recent fiscal year, Neurones reported revenue of $950M and EBITDA of $126M.

Neurones expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Neurones valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$983M	XXX	$950M	XXX	XXX	XXX
Gross Profit	n/a	XXX	$593M	XXX	XXX	XXX
Gross Margin	n/a	XXX	62%	XXX	XXX	XXX
EBITDA	$103M	XXX	$126M	XXX	XXX	XXX
EBITDA Margin	10%	XXX	13%	XXX	XXX	XXX
EBIT	$83.2M	XXX	$91.4M	XXX	XXX	XXX
EBIT Margin	8%	XXX	10%	XXX	XXX	XXX
Net Profit	$58.2M	XXX	$61.6M	XXX	XXX	XXX
Net Margin	6%	XXX	6%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Neurones including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $983M. EBITDA for the last twelve months was $103M. In the most recent fiscal year, Neurones achieved $950M in revenue and $126M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$983M	Analyst estimates available to subscribers	$950M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	n/a	Analyst estimates available to subscribers	$593M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	n/a	Analyst estimates available to subscribers	62.5% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$103M	Analyst estimates available to subscribers	$126M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	10.5% EBITDA margin	Analyst estimates available to subscribers	13.3% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$83.2M	Analyst estimates available to subscribers	$91.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	8.5% EBIT margin	Analyst estimates available to subscribers	9.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$58.2M	Analyst estimates available to subscribers	$61.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	5.9% net profit margin	Analyst estimates available to subscribers	6.5% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Neurones

This financial data table provides comprehensive performance metrics for Neurones, a company based in France. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Neurones generated $983M in revenue over the last twelve months.
The company achieved $103M in EBITDA over the last twelve months.
Net income over the last twelve months reached $58.2M.

Fiscal Year Performance

In the most recent fiscal year, Neurones reported $950M in total revenue.
Fiscal year EBITDA was $126M.
The company maintained a gross profit margin of 62.5% in the most recent fiscal year.
EBITDA margin for the fiscal year was 13.3%.
Net profit margin reached 6.5% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Neurones. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Neurones Stock Performance

Neurones has current market cap of EUR 969M (or $1.1B), and EV of EUR 685M (or $803M).

Market Cap Evolution

Neurones Stock Data

As of September 12, 2025, Neurones's stock price is EUR 40 (or $47).

See Neurones trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$803M	$1.1B	XXX	XXX	XXX	XXX	$2.39

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Neurones Valuation Multiples

Neurones's trades at 0.8x EV/Revenue multiple, and 6.4x EV/EBITDA.

See valuation multiples for Neurones and 15K+ public comps

Neurones Financial Valuation Multiples

As of September 12, 2025, Neurones has market cap of $1.1B and EV of $803M.

Equity research analysts estimate Neurones's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Neurones has a P/E ratio of 19.5x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$1.1B	XXX	$1.1B	XXX	XXX	XXX
EV (current)	$803M	XXX	$803M	XXX	XXX	XXX
EV/Revenue	0.8x	XXX	0.8x	XXX	XXX	XXX
EV/EBITDA	7.8x	XXX	6.4x	XXX	XXX	XXX
EV/EBIT	9.6x	XXX	8.8x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	19.5x	XXX	18.4x	XXX	XXX	XXX
EV/FCF	n/a	XXX	9.5x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Neurones Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Neurones Margins & Growth Rates

Neurones's last 12 month revenue growth is 5%

Neurones's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Neurones's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Neurones's rule of X is 24% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Neurones and other 15K+ public comps

Neurones Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	5%	XXX	5%	XXX	XXX	XXX
EBITDA Margin	10%	XXX	13%	XXX	XXX	XXX
EBITDA Growth	7%	XXX	-7%	XXX	XXX	XXX
Rule of 40	19%	XXX	19%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	24%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	53%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial